In the BioHarmony Drug Report Database
Tranylcypromine
Parnate (tranylcypromine) is a small molecule pharmaceutical. Tranylcypromine was first approved as Parnate on 1985-08-16. It is used to treat depressive disorder and post-traumatic stress disorders in the USA. The pharmaceutical is active against amine oxidase [flavin-containing] B and amine oxidase [flavin-containing] A. In addition, it is known to target lysine-specific histone demethylase 1A and prostacyclin synthase.
Trade Name
|
Parnate |
|---|---|
Common Name
|
tranylcypromine |
ChEMBL ID
|
CHEMBL3989843 |
Indication
|
depressive disorder, post-traumatic stress disorders |
Drug Class
|
Image (chem structure or protein)